All Stories

  1. Interaction of the NSAID cyclooxygenase inhibitor, acemetacin, with human serum albumin: an experimental and computational modelling investigation
  2. Binding interactions between ar-turmerone and human serum albumin: mechanistic and biophysical insights
  3. Assessing the molecular interaction between a COVID-19 drug, nirmatrelvir, and human serum albumin: calorimetric, spectroscopic, and microscopic investigations
  4. Molecular interaction of a protease inhibitor, leupeptin, with human serum albumin: Insights from calorimetry, spectroscopy, microscopy, and computational approaches
  5. Multifaceted analysis of bempedoic acid binding to subdomain IIA of human serum albumin
  6. Exploring nalbuphine loaded chitosan nanoparticles for effective pain management through intranasal administration: a comparative study
  7. Nirmatrelvir, A COVID‐19 Drug, and Human Serum Albumin: Computational Analysis of Their Molecular Interactions
  8. Deciphering the binding mode and structural perturbations in floxuridine-human serum albumin complexation with spectroscopic, microscopic, and computational techniques
  9. Elucidating the influence of some metal ions on the binding of antimalarial drugs to human serum albumin: spectroscopic approach
  10. Unveiling the molecular interaction of hepatitis B virus inhibitor, entecavir with human serum albumin through computational, microscopic and spectroscopic approaches
  11. Advances in Metal-Based Compounds as Emerging Therapeutics for Cancer Treatment
  12. The fluorescence signal of albumin-bound bilirubin to monitor drug-induced bilirubin displacement from human serum albumin
  13. Use of computational and wet lab techniques to examine the molecular association between a potent hepatitis C virus inhibitor, PSI-6206 and human serum albumin
  14. Shedding light on the molecular interaction between the Hepatitis B virus inhibitor, clevudine, and human serum albumin: Thermodynamic, spectroscopic, microscopic, and in silico analyses
  15. Molecular Recognition between Anticancer Drug, Regorafenib and Human Serum Albumin: Interaction Revisited
  16. DIFFERENTIAL STABILIZING EFFECTS OF BUFFERS ON STRUCTURAL STABILITY OF BOVINE SERUM ALBUMIN AGAINST UREA DENATURATION
  17. Computational View of β-Asarone–Human Serum Albumin Interaction
  18. Targeting the Nalidixic Acid Binding Site on Human Serum Albumin Through Computational Approach: A Re-Investigation
  19. Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach
  20. Lysine modification of human serum albumin and its effect on protein conformation and nalidixic acid binding
  21. Serum albumin: clinical significance of drug binding and development as drug delivery vehicle
  22. Intermolecular recognition between pyrimethamine, an antimalarial drug and human serum albumin: Spectroscopic and docking study
  23. Meet Our Editorial Board Member
  24. Biophysical and computational view on the in vitro combination between an anticancer drug, saracatinib and human serum albumin
  25. Interaction mechanism of an antimalarial drug, sulfadoxine with human serum albumin
  26. Biophysical and in silico investigations of the molecular association between a potent RNA polymerase inhibitor, thiolutin and human serum albumin
  27. Docking Evaluation of the Interaction Between Green Tea Active Ingredient, l-Theanine and Human Serum Albumin
  28. Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies
  29. Exploring the interaction mechanism of a dicarboxamide fungicide, iprodione with bovine serum albumin
  30. Biophysical and computational approaches to unravel the molecular interaction mechanism of bromodeoxyuridine, a proliferative marker with human serum albumin
  31. Combination mode of antimalarial drug mefloquine and human serum albumin: Insights from spectroscopic and docking approaches
  32. Exploring the interaction between tyrphostin 9 and human serum albumin using biophysical and computational methods
  33. Fluorometric and Docking Analysis of the Complex Formation between an Anti-Cancer Drug, Chlorambucil and Bovine Serum Albumin
  34. Biomolecular interaction of a platelet aggregation inhibitor, 3,4-methylenedioxy-β-nitrostyrene with human serum albumin: multi-spectral and computational characterization
  35. Molecular interaction study of an anticancer drug, ponatinib with human serum albumin using spectroscopic and molecular docking methods
  36. Exploring ligand–protein interaction: A laboratory exercise on herbicide binding to plasma transport protein
  37. Amplification-free and direct fluorometric determination of telomerase activity in cell lysates using chimeric DNA-templated silver nanoclusters
  38. Green synthesized-gold nanoparticles in photothermal therapy of breast cancer
  39. Probing the interaction of 2,4-dichlorophenoxyacetic acid with human serum albumin as studied by experimental and computational approaches
  40. Comparison of pendimethalin binding properties of serum albumins from various mammalian species
  41. Spectroscopic studies on the interaction of green synthesized-gold nanoparticles with human serum albumin
  42. Effect of Various Polyols on the Acid-Denatured States of Champedak Galactose-Binding Lectin
  43. Biophysical and computational characterization of vandetanib–lysozyme interaction
  44. Interactive association between RhoA transcriptional signaling inhibitor, CCG1423 and human serum albumin: Biophysical and in silico studies
  45. Increased Chemical Stability of Bacillus Licheniformis α-Amylase Upon Acetylation
  46. Comprehensive insight into the binding of sunitinib, a multi-targeted anticancer drug to human serum albumin
  47. Alcohol-induced structural transitions in the acid-denatured Bacillus licheniformis α-amylase
  48. Interaction of stattic, a STAT3 inhibitor with human serum albumin: spectroscopic and computational study
  49. Acid-Induced Unfolding of Champedak Galactose-Binding Lectin
  50. A Comparative Analysis of Protein Stabilizing Potential of Honey and Simulated Honey Sugar Cocktail
  51. Evaluation of pendimethalin binding to human serum albumin: Insights from spectroscopic and molecular modeling approach
  52. Binding of an anticancer drug, axitinib to human serum albumin: Fluorescence quenching and molecular docking study
  53. Characteristics and thermodynamics of the interaction of 6-shogaol with human serum albumin as studied by isothermal titration calorimetry
  54. Characterization of the binding of an anticancer drug, lapatinib to human serum albumin
  55. Fluorometric and molecular docking investigation on the binding characteristics of SB202190 to human serum albumin
  56. Influence of Buffer Composition and Calcium Chloride on GdnHCl Denaturation of Bacillus licheniformis α-Amylase
  57. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking
  58. Conformational analysis of champedak galactose-binding lectin under different urea concentrations
  59. On the purported “backbone fluorescence” in protein three-dimensional fluorescence spectra
  60. Interaction of an anticancer drug, gefitinib with human serum albumin: insights from fluorescence spectroscopy and computational modeling analysis
  61. Intrinsic Fluorescence as a Spectral Probe for Protein Denaturation Studies in the Presence of Honey
  62. Exploring the interaction between the antiallergic drug, tranilast and human serum albumin: Insights from calorimetric, spectroscopic and modeling studies
  63. Diazepam & ketoprofen-induced stabilization of human serum albumin against urea denaturation
  64. Supramolecular interaction of 6-shogaol, a therapeutic agent of Zingiber officinale with human serum albumin as elucidated by spectroscopic, calorimetric and molecular docking methods
  65. Interaction of flavokawain B with lysozyme: A photophysical and molecular simulation study
  66. Spectrofluorometric and Molecular Docking Studies on the Binding of Curcumenol and Curcumenone to Human Serum Albumin
  67. Warfarin Binding to Native and Structurally-Altered Human Serum Albumins
  68. Targeting chemical and thermal stability of ovalbumin by simulated honey sugar cocktail
  69. A comparative analysis on the binding characteristics of various mammalian albumins towards a multitherapeutic agent, pinostrobin
  70. Towards increasing chemical and thermal stability of lysozyme with a simulated honey sugar cocktail
  71. Gastroprotective Effect of Ethanolic Extract ofCurcuma xanthorrhizaLeaf against Ethanol-Induced Gastric Mucosal Lesions inSprague-DawleyRats
  72. Molten Globule-Like Partially Folded State ofBacillus licheniformis α-Amylase at Low pH Induced by 1,1,1,3,3,3-Hexafluoroisopropanol
  73. Probing the Interaction of a Therapeutic Flavonoid, Pinostrobin with Human Serum Albumin: Multiple Spectroscopic and Molecular Modeling Investigations
  74. Halogenol- versus alkanol-induced structural transitions of acid-denatured glucoamylase: Characterization of alcohol-induced states
  75. Does Recovery in the Spectral Characteristics of GdnHCl-DenaturedBacillus licheniformisα-Amylase Due to Added Calcium Point towards Protein Stabilization?
  76. Structural stability of commercial ficin under different denaturing conditions
  77. Chemical Analysis ofBrassica juncea(L.) Czern var. Ensabi
  78. Honey-Induced Protein Stabilization as Studied by Fluorescein Isothiocyanate Fluorescence
  79. Stabilizing Effect of Various Polyols on the Native and the Denatured States of Glucoamylase
  80. Protein stabilizing potential of simulated honey sugar cocktail under various denaturation conditions
  81. Multispectroscopic and Molecular Modeling Approach To Investigate the Interaction of Flavokawain B with Human Serum Albumin
  82. Formation of molten globule-like state during acid denaturation of Aspergillus niger glucoamylase
  83. Conformational destabilization of Bacillus licheniformis α-amylase induced by lysine modification and calcium depletion.
  84. Protein Profiling of Brassica juncea (L.) Czern var. Ensabi at Different Developmental Stages
  85. Calcium-induced stabilization of -amylase against guanidine hydrochloride denaturation
  86. Succinylation-induced Conformational Destabilization of Lysozyme as Studied by Guanidine Hydrochloride Denaturation
  87. Bromophenol Blue Binding to Mammalian Albumins and Displacement of Albumin-Bound Bilirubin
  88. Bromophenol Blue Binding as a Probe to Study Urea and Guanidine Hydrochloride Denaturation of Bovine Serum Albumin
  89. Resistance towards calcium induced bilirubin dependent hemolysis in porcine erythrocytes
  90. Spectroscopic studies on the binding of bromocresol purple to different serum albumins and its bilirubin displacing action
  91. PLGA-microsphere mediated clearance of bilirubin in temporarily hyperbilirubinemic rats: An alternate strategy for the treatment of experimental jaundice
  92. Influence of Fluoro, Chloro and Alkyl Alcohols on the Folding Pathway of Human Serum Albumin
  93. Interaction of bilirubin with sealed and human serum albumin-entrapped sealed membranes
  94. Molten-globule like partially folded states of human serum albumin induced by fluoro and alkyl alcohols at low pH
  95. Liposome‐Bilirubin Interaction: A Novel Strategy to Eliminate Bilirubin from Systemic Circulation
  96. Interaction of bilirubin with native and protein-depleted human erythrocyte membranes
  97. Behavior of various mammalian albumins towards bilirubin binding and photochemical properties of different bilirubin–albumin complexes
  98. Bilirubin binding properties of pigeon serum albumin and its comparison with human serum albumin
  99. Salt-induced refolding in different domains of partially folded bovine serum albumin
  100. Modulation in the photosensitivity of albumin-bound bilirubin
  101. Effect of phospholipase C, trypsin and neuraminidase on binding of bilirubin to mammalian erythrocyte membranes
  102. Understanding the role of internal lysine residues of serum albumins in conformational stability and bilirubin binding
  103. Enhanced bilirubin binding to different mammalian erythrocytes in the presence of magnesium ions
  104. Differential accessibility of bilirubin to erythrocyte membrane vesicles bearing different structural features
  105. On the modulation of photoinduced fluorescence enhancement and conformational stability of albumin-bound bilirubin:
  106. Use of Domain Specific Ligands to Study Urea-Induced Unfolding of Bovine Serum Albumin
  107. Anion-induced stabilization of human serum albumin prevents the formation of intermediate during urea denaturation
  108. Effect of pH and temperature on the binding of bilirubin to human erythrocyte membranes
  109. Role of salt bridge(s) in the binding and photoconversion of bilirubin bound to high affinity site on human serum albumin
  110. Chloroform-induced conformational changes in the bound pigmentin bilirubin-albumin complexes
  111. Erratum
  112. Anion-induced refolding of human serum albumin under low pH conditions
  113. Molten globule‐like state of human serum albumin at low pH
  114. Effect of lysine modification on the conformation and indomethacin binding properties of human serum albumin
  115. Use of fluorescence enhancement technique to study bilirubin–albumin interaction
  116. A comparative study on the extraction of membrane-bound bilirubin from erythrocyte membranes using various methods
  117. Differential resistance to calcium-induced bilirubin-dependent hemolysis in mammalian erythrocytes
  118. Visualization of serum albumin on electrophoretic gels using the specific ligand bilirubin
  119. Binding of Bilirubin to Mammalian Erythrocytes
  120. Calcium-induced bilirubin-dependent hemolysis of human erythrocytes
  121. Protein proteinase inhibitors from avian egg whites
  122. Probing structure-activity relationship in diamine oxidase reactivities of lysine and arginine residues
  123. Binding of bilirubin to erythrocytes from different mammalian species
  124. Experimental determination of the free energy of unfolding of proteins
  125. Alkaline azobilirubin color reaction to determine sodium azide
  126. Memorization through games
  127. Binding of bilirubin to goat serum albumin: Determination of binding constant
  128. Effect of acetylation on conformation and bilirubin-binding properties of goat serum albumin
  129. Interference of Sodium Azide with the Quantitation of Bilirubin: Modification of Fog′s Method to Eliminate Azide Interference
  130. Involvement of lysine residues of goat serum albumin in high-affinity binding of bilirubin
  131. Biochemical education in leisure
  132. Probing the Determinants of Protein Solubility with Amino Acid Modification1
  133. Immunological exercises for beginners
  134. Essential Molecular Biology: A Practical Approach Volume I
  135. A look into enzyme kinetics: some introductory experiments
  136. Size exclusion chromatography and size exclusion HPLC of proteins
  137. Binding of bromophenol blue to bovine serum albumin and its succinylated forms
  138. Biochemistry through cartoons — Understanding Enzymes
  139. Biochemical education in Kashmir, India
  140. Mini review: protein folding: a problem of today
  141. Biochemistry and roles of glycophorin A
  142. Influence of succinylation of bovine serum albumin on its conformation and bilirubin binding
  143. A Correlation between Changes in Conformation and Molecular Properties of Bovine Serum Albumin upon Succinylation1